16-Dec-2025
‘Tubuloids’ offer a realistic platform for modeling chronic kidney disease
Institute of Science TokyoPeer-Reviewed Publication
A human ‘tubuloid’ model captures the slow progression of chronic kidney disease (CKD), addressing key limitations of animal and stem-cell models. Researchers from Institute of Science Tokyo grew 3D tubuloid structures from adult patient kidney cells and exposed them to the chemotherapy drug cisplatin to replicate key features of CKD: DNA damage, cellular senescence, inflammation, and fibrosis. This realistic platform provides a new way to develop and test treatments for a condition affecting millions globally.
- Journal
- Advanced Healthcare Materials
- Funder
- Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Society for the Promotion of Science, Tokyo Medical and Dental University, Uehara Memorial Foundation, MSD Life Science Foundation, Takeda Science Foundation, Bayer Yakuhin, Ltd., Kato Memorial Bioscience Foundation, The Waksman Foundation of Japan, Inc., Pharmacodynamics Research Society, Japan Agency for Medical Research and Development